Page 85 - IJB-10-3
P. 85

International Journal of Bioprinting                                  3D printing technology in neurotrauma




            Qian et al. fabricated a PCL conduit loading with PDA-  Conflict of interest
            coated gold  nanoparticles  by  an extrusion  printing   The authors declare no conflicts of interest.
            process.  They found that the scaffold could provide a
                  183
            favorable microenvironment for BMSCs and Schwann   Author contributions
            cells  in vitro. After loading with BMSCs and Schwann
            cells, they demonstrated that the conduit could promote   Conceptualization: Yu Hu
            axonal regeneration and remyelination in a sciatic nerve   Funding acquisition: Yu Hu, Wenbi Wu
            defect model. 183                                  Supervision: Maling Gou
                                                               Visualization: Wenbo He
            4. Conclusion and future outlook                   Writing – original draft: Wenbo He, Chongxi Xu, Wenbi
                                                                  Wu, Yuchen Chen, Jingxuan Hou, Zhouhaoran Chen
            The emerging 3D printing technology has the characteristics   Writing – review & editing: Jianguo Xu, Yu Hu, Maling Gou
            of design flexibility, personalized customization, and
            controllable manufacturing accuracy. Taking advantage of   Ethics approval and consent to participate
            the advanced technology, we could fabricate functionalized
            neural constructs based on multiple strategies, such as   Not applicable.
            biomaterials, physical stimulation, bioactive substances,
            cell  transplantation, and  their  combination,  for  efficient   Consent for publication
            neurotrauma  treatment.  At  present,  although  significant   Not applicable.
            progresses have been achieved in the application of 3D
            printing in neurotrauma treatment, challenges still remain.   Availability of data
            First, in order to accurately manufacture constructs with
            customized functions, the 3D printing system needs to   Not applicable.
            be optimized, especially in terms of accuracy and speed.
            Second, the biomaterials available for printing are limited.   References
            The properties of printable biomaterials for neurotrauma,
            such as degradability, biocompatibility, and mechanical   1.   Peppiatt CM, Howarth C, Mobbs P, Attwell D. Bidirectional
                                                                  control of CNS capillary diameter by pericytes.  Nature.
            properties, could be further improved. Choosing a     2006;443(7112):700-704.
            combination of various biomaterials may be an alternative      doi: 10.1038/nature05193
            option. Third, for the purpose of clinically translating
            3D-printed  devices  into  applications  for  neurotrauma   2.   Bican O, Minagar A, Pruitt AA. The spinal cord: a review of
            treatment, it is still a huge challenge to fabricate constructs      functional neuroanatomy. Neurol Clin. 2013;31(1):1-18.
                                                                  doi: 10.1016/j.ncl.2012.09.009
            suitable for humans and test them on large animals or even
            conduct  clinical trials.  More importantly,  exploring  and   3.   Catala M, Kubis N. Gross anatomy and development of
            elucidating the repair mechanism of a damaged nervous   the peripheral nervous system.  Handb Clin Neurol. 2013;
            system is of great significance and can provide direction   115:29-41.
            for the design of new 3D-printed products. Finally,      doi: 10.1016/b978-0-444-52902-2.00003-5
            3D-printed constructs with synergetic combination of   4.   Suter T, Jaworski A. Cell migration and axon guidance at
            multiple neurotrauma treatment strategies to achieve   the border between central and peripheral nervous system.
            multi-angle and sequential treatment are expected to lead   Science (New York, NY). 2019;365(6456).
            to breakthroughs in the future.                       doi: 10.1126/science.aaw8231
                                                               5.   Lozano JCM, Gomez RM, Sanabria AGZ, Jubiz G, Valderrama
            Acknowledgments                                       S. Genetic aspects of glial cells regarding neurodegenerative
                                                                  diseases. Curr Pharm Des. 2018;24(15):1727-1735.
            None.                                                 doi: 10.2174/1381612823666170828134055

            Funding                                            6.   Shafiee A, Ahmadi H, Taheri B, et al. Appropriate scaffold
                                                                  selection for CNS tissue engineering.  Avicenna  J  Med
            This work was supported by National Natural Science   Biotechnol. 2020;12(4):203-220.
            Foundation of China (grant number: 82001320), Key R&D   7.   Alilain WJ, Horn KP, Hu H, Dick TE, Silver J. Functional
            projects in Sichuan Province (2022YFS0319), and Post-  regeneration of respiratory pathways after spinal cord injury.
            Doctor Research Project, West China Hospital, Sichuan   Nature. 2011;475(7355):196-200.
            University (No. 2023HXBH081).                         doi: 10.1038/nature10199




            Volume 10 Issue 3 (2024)                        77                                doi: 10.36922/ijb.2311
   80   81   82   83   84   85   86   87   88   89   90